Home > News > World
Monday August 25, 2014 MYT 11:45:03 AM
Monday August 25, 2014 MYT 11:46:18 AM
TOKYO (Reuters) - Japan could offer an unapproved drug under certain circumstances to help treat the deadly Ebola virus even before the World Health Organization has decided to make a request for the drug, the country's top government spokesman said on Monday.
Chief Cabinet Secretary Yoshihide Suga told a news conference that Japan would cooperate with the WHO and was ready to make an international contribution.
"I am informed that medical professionals could make a request for T-705 in an emergency even before a decision by the WHO. In that case, we would like to respond under certain criteria," he said.
T-705 is the developmental code for the influenza drug favipiravir. Japan's Fujifilm Holdings Corp and U.S. partner MediVector are in talks with the U.S. Food and Drug Administration to submit an application to expand the use of favipiravir as a treatment for Ebola.
The Ebola epidemic in West Africa has killed more than 1,000 people and prompted the WHO to declare an international health emergency.
(Reporting by Kaori Kaneko; Editing by Chris Gallagher)
Killing of Cecil the lion triggers probe by U.S. agency - source
Wisma Putra looking at other options after Russian veto on MH17
United States launches probe into killing of Cecil the lion
U.S. agency probes possible legal violation in lion killing - source
Religious assailant attacks Jerusalem Gay Pride parade, wounding six
Pacific trade negotiators chase elusive final deal in tough talks
Bon Odori festival thrills crowd with folk dances and fireworks
Uber launches car leasing unit, makes entry into financial services
Slam dunk success on the cards
Copyright © 1995-2015 Star Media Group Berhad (ROC 10894D)(Formerly known as Star Publications (Malaysia) Berhad)